| |
| Issue |
Title |
| |
| No 2 (2025) |
Mosunetuzumab budget impact analysis in patients with recurrent or refractory follicular lymphoma |
Abstract
PDF (Rus)
|
|
I. S. Krysanov, E. V. Makarova, V. S. Krysanova, V. Yu. Ermakova, D. V. Kurkin, Yu. A. Kolosov |
| |
| No 2 (2025) |
Potential social impact of electronic tobacco heating devices: modeling results |
Abstract
PDF (Rus)
|
|
A. V. Rozanov, L. D. Popovich, S. V. Svetlichnaya |
| |
| No 2 (2025) |
A digital solution for optimizing antimicrobial prophylaxis in surgery |
Abstract
PDF (Rus)
|
|
K. A. Koshechkin, O. A. Leontyeva, S. S. Leontyev, A. M. Uridin |
| |
| No 2 (2024) |
Socio-economic burden of chronic graft-versus-host disease after allogenic bone marrow transplantation |
Abstract
PDF (Rus)
|
|
A. S. Kolbin, Yu. M. Gomon, M. A. Proskurin, Ju. E. Balykina |
| |
| No 4 (2023) |
Pharmacoeconomic study of the effectiveness of cytogenetic studies in patients with MM before prescribing first-line therapy |
Abstract
PDF (Rus)
|
|
Yu. A. Zabolotneva, I. S. Krysanov |
| |
| No 4 (2023) |
Economic analysis of the use of drugs for the treatment of hemophilia A, B and Willebrand's disease |
Abstract
PDF (Rus)
|
|
D. S. Fokina, O. V. Zhukova, A. L. Khokhlov, S. A. Volkova |
| |
| No 4 (2023) |
Clinical-economic evaluation of distance education and blood glucose level monitoring in adults with diabetes mellitus |
Abstract
PDF (Rus)
|
|
V. V. Omelyanovskiy, V. K. Fediaeva |
| |
| No 3 (2023) |
An economic evaluation of vaccination in children against meningococcal infection in Moscow |
Abstract
PDF (Rus)
|
|
S. V. Svetlichnaya, L. N. Mazankova, L. D. Popovich, L. A. Elagina |
| |
| No 2 (2023) |
Economic aspects of the fixed combinations of lipid lowering medicines in group risks patients |
Abstract
PDF (Rus)
|
|
M. V. Zhuravleva, M. Yu. Frolov, E. A. Luchinin, K. A. Kokushkin, E. D. Laryushkina, T. R. Kameneva, E. V. Kuznetsova |
| |
| No 2 (2023) |
Socio-economic burden of atrial fibrillation in the Russian Federation: dynamics over 12 years |
Abstract
PDF (Rus)
|
|
A. P. Kasimova, O. S. Tufanova, A. S. Kolbin |
| |
| No 2 (2023) |
Drugs influencing on PCSK9 activity: modelling of efficacy in patients who had myocardial infarction with uncontrolled dyslipidemia |
Abstract
PDF (Rus)
|
|
V. I. Ignatyeva, A. V. Kontsevaya, O. M. Drapkina, E. V. Derkach |
| |
| No 4 (2022) |
Optimization of laboratory support costs in a multidisciplinary hospital: possible solutions. Emphasis on the medical information system |
Abstract
PDF (Rus)
|
|
A. S. Fedorenko, A. T. Burbello, L. B. Gaikova, E. A. Orishak, E. L. Lataria, O. V. Granatovich, M. V. Pokladova, M. A. Korosteleva |
| |
| No 3 (2022) |
Updated guidelines of reporting pharmacoeconomics and health technology assessment results from 2022 ISPOR (CHEERS 2022) |
Abstract
PDF (Rus)
|
|
M. A. Truuts, A. A. Kurilev, A. S. Kolbin |
| |
| No 2 (2022) |
Economic prognosis from vaccination against meningococcal infection inclusion into the National calendar of prophylactic vaccines in children of first age old |
Abstract
PDF (Rus)
|
|
L. D. Popovich, D. A. Vakhrusheva, S. V. Svetlichnaya |
| |
| No 1 (2022) |
Ademetionine treatment cost analysis of patients with intrahepatic cholestasis and non-alcoholic fatty disease |
Abstract
PDF (Rus)
|
|
M. V. Zhuravleva, G. V. Kukushkin, E. V. Luchinina, T. V. Shelekhova, T. R. Kameneva, E. V. Kuznetsova, E. A. Luchinin |
| |
| No 3 (2021) |
Optimization of chronic lymphocytic leukemia treatment using game theory |
Abstract
PDF (Rus)
|
|
A. S. Luchinin, V. V. Strugov |
| |
| No 3 (2021) |
Health technology assessment: factors affecting the results |
Abstract
PDF (Rus)
|
|
I. N. Kozhanova |
| |
| No 3 (2021) |
Clinical and economic aspects of the use of OneTouch glucose meters for the screening of diabetes mellitus |
Abstract
PDF (Rus)
|
|
A. E. Cheberda, D. Yu. Belousov |
| |
| No 1 (2021) |
Resource consumption and patient employability during systemic therapy and biological therapy |
Abstract
PDF (Rus)
|
|
L. S. Kruglova, A. A. Hotko |
| |
| No 4 (2019) |
Hospital-based health technology assessment in Russian Federation: opportunities and prospects |
Abstract
PDF (Rus)
|
|
Y. M. Gomon |
| |
| No 4 (2019) |
Clostridium difficile associated infection: view of hospital-based health technology assessment |
Abstract
PDF (Rus)
|
|
Y. M. Gomon |
| |
| No 2 (2018) |
Multicriteria analysis of the assortment of innovative drugs in oncohematology as a tool for supporting decision-making in the field of drug provision |
Abstract
PDF (Rus)
|
|
S. V. Nedogoda, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova, E. A. Popova |
| |
| No 1 (2014) |
Health technology assessment of hyaluronans in osteoarthritis treatment |
Abstract
PDF (Rus)
|
|
A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin |
| |
| No 2 (2015) |
Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices - Modeling Studies |
Abstract
PDF (Rus)
|
|
M. C. Weinstein, Bernie O’Brien, John Hornberger, Joseph Jackson, Magnus Johannesson, Chris Mccabe, Bryan R. Luce, A. V. Pavlysh, A. S. Kolbin |
| |
| 1 - 24 of 27 Items |
1 2 > >>
|
